Emtricitabine

( DrugBank: Emtricitabine / KEGG DRUG: Emtricitabine )

---

5 diseases

13. 多発性硬化症／視神経脊髄炎

---

臨床試験数 : 3,898 / 薬物数 : 2,785 - (DrugBank : 360) / 標的遺伝子数 : 265 - 標的パスウェイ数 : 239 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

25. 進行性多巣性白質脳症

---

臨床試験数 : 31 / 薬物数 : 42 - (DrugBank : 23) / 標的遺伝子数 : 7 - 標的パスウェイ数 : 37 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

93. 原発性胆汁性胆管炎

---

臨床試験数 : 371 / 薬物数 : 286 - (DrugBank : 56) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 105 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

265. 脂肪萎縮症

---

臨床試験数 : 133 / 薬物数 : 176 - (DrugBank : 58) / 標的遺伝子数 : 30 - 標的パスウェイ数 : 102 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

325. 遺伝性自己炎症疾患

---

臨床試験数 : 12 / 薬物数 : 18 - (DrugBank : 7) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 37 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries